TVARDI THERAPEUTICS, INC. Increase (Decrease) in Prepaid Expense and Other Assets
TVARDI THERAPEUTICS, INC. (TVRD) reported Increase (Decrease) in Prepaid Expense and Other Assets of $576.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-14
- TVARDI THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $958.00K, a 32.14% increase year-over-year.
- TVARDI THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$382.00K, a 138.51% decline year-over-year.
- TVARDI THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$1.26M.
- TVARDI THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$153.00K.
- TVARDI THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $308.00K.
- TVARDI THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$3.17M.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $958.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $576.00K 10-Q · filed 2026-08-14 | -$680.00K derived: sum of 3 quarters · filed 2026-08-14 | -$833.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$382.00K 10-Q · filed 2026-05-08 | -$1.64M derived: sum of 2 quarters · filed 2026-05-08 | -$1.79M derived: sum of 3 quarters · filed 2026-05-08 | -$1.07M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$1.41M derived: sum of 2 quarters · filed 2026-03-31 | -$684.00K derived: sum of 3 quarters · filed 2026-08-14 | $308.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | -$153.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $572.00K derived: sum of 2 quarters · filed 2026-08-14 | $1.56M 10-Q · filed 2025-11-13 | $371.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $725.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $1.72M 10-Q · filed 2026-08-14 | $524.00K derived: sum of 3 quarters · filed 2026-08-14 | $136.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $992.00K 10-Q · filed 2026-05-08 | -$201.00K derived: sum of 2 quarters · filed 2026-05-08 | -$589.00K derived: sum of 3 quarters · filed 2026-05-08 | |
| 2024-12-31 | -$1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$1.58M derived: sum of 2 quarters · filed 2026-03-31 | -$3.17M 10-K · filed 2026-03-31 | |
| 2024-09-30 | -$388.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$1.97M 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | -$1.59M 10-Q · filed 2025-08-14 | |||
| 2015-06-30 | $303.00K 10-Q · filed 2015-08-10 | |||
| 2014-06-30 | $184.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $561.00K 10-Q · filed 2015-08-10 | ||
| 2014-03-31 | $377.00K 10-Q · filed 2014-05-12 | |||
| 2013-06-30 | -$44.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $22.00K 10-Q · filed 2014-08-07 | ||
| 2013-03-31 | $66.00K 10-Q · filed 2014-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |